Clinical Trial Update: An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation. [Phase 1]

View source ↗

Summary

An exploratory Phase 1 study evaluating FE 999302 administered with Follitropin Delta at different timing intervals during controlled ovarian stimulation for in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• FE 999302
• Follitropin Delta (follicle-stimulating hormone delta)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Infertility | Phase 1 | Status: TERMINATED